VIENNA—Estrogen receptor negative breast cancer might be prevented by strategies under investigation including HER2-targeting, vaccination and treatment with metformin or retinoids. Powel Brown MD, Chairman of the Department of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center in Houston, summarized the evidence for Oncology Times reporter Sarah.
You may also like...
The TH3RESA study: TDM-1 doubles progression free survival in HER-2 positive refractory metastatic breast cancer. 19 Nov, 2013 The WIN consortium meets in Paris – a boost for cancer science 17 Jul, 2013 Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically 9 Aug, 2013 Audio Journal of Oncology Volume 16 Number 10 25 May, 2008
- Previous story Preventing ER-Positive Breast Cancer—Latest from IBIS 1, 2 and 3
- Next story Genetic Tests for Breast Cancer Late Recurrence Risk—Not Yet Ready for Prime Time
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014